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The proteasome has an essential function in the intracellular
degradation of protein in eukaryotic cells. We found that the
dimeric quinone reductase Lot6 uses the flavin mononucleotide
(FMN)-binding site to bind to the 20S proteasome with a 1:2
stoichiometry—that is, one 20S proteasome molecule can
associate with two quinone reductases. Furthermore, reduction
of the FMN cofactor by either NADH or light irradiation results in
the binding of the b-Zip transcription factor Yap4 to the Lot6–
proteasome complex, indicating that recruitment of the tran-
scription factor depends on the redox state of the quinone
reductase. Here, we show that binding of Yap4 to the complex
not only protects it from ubiquitin-independent proteasomal
degradation, but also regulates its cellular localization. In non-
stressed wild-type cells, we did not detect any Yap4 in the
nucleus, whereas Yap4 was present in the nuclei from quinone-
stressed yeast cultures. Thus, the Lot6–proteasome complex can
be regarded as a redox switch in which the quinone reductase
acts as a sensor for oxidative stress.
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INTRODUCTION
Organisms have evolved cellular responses to cope with stress
caused by reactive oxygen species (Halliwell & Gutteridge, 1984).
As these harmful molecules are constantly being generated, all
aerobically growing cells maintain an assemblage of antioxidants
and enzymes to maintain a state of redox balance (Toone et al,
2001). In the yeast Saccharomyces cerevisiae, the b-Zip transcrip-
tion factor Yap1 is controlled primarily by redox-sensitive nuclear
export, regulating its nuclear accumulation on activation by H2O2
(Delaunay et al, 2000). However, Yap1 is not directly oxidized by
H2O2; instead, a thiol peroxidase Gpx3 has been identified to
promote oxidation of Yap1 (Delaunay et al, 2002). Other
molecular mechanisms to sense oxidative stress involve iron–
sulphur centres, haem or flavin (Bauer et al, 1999). In Klebsiella,
Azotobacter and Enterobacter, the activity of NifA, a trans-
criptional activator of nitrogen fixation genes, is inhibited by the
redox-sensitive protein NifL in response to elevated levels of
oxygen and fixed nitrogen in vivo (Dixon, 1998). NifL is a
flavoprotein that contains FAD as a redox-responsive cofactor,
which inhibits NifA activity in vitro in the oxidized but not in the
reduced form. Although details of the interaction of NifL with NifA
are still unclear, this system so far represents the only example of
flavin-dependent transcriptional regulation.
Several species have been shown to have flavin-dependent
enzymes that allow the two-electron reduction of quinones to the
hydroquinone form to avoid the generation of one-electron
reduced semiquinone that is known to cause oxidative stress
(Deller et al, 2008). One of the human NADPH:quinone
reductases (NQOs) was recently shown to interact with the 20S
proteasome. In the presence of NADH, the NQO1–proteasome
complex recruits transcription factors p53 and p73 (Asher et al,
2001), presumably to protect them from proteasomal degradation
(Asher & Shaul, 2005). Remarkably, degradation of p53 by the 20S
proteasome is inhibited in the presence of excess NQO1 and
NADH, suggesting that NQO1 directly regulates the proteasomal
degradation of this protein. In vitro binding assays in the presence
of the NQO1 cofactors NADþ , FAD or NADH showed that the
binding of NQO1 to p53 increased in the presence of NADH
(Asher et al, 2005). The involvement of NQO1 in the accumula-
tion of p53 suggests that redox reactions controlled by oxido-
reductases such as NQO1 might therefore be important in
determining the intracellular level of p53. However, the molecular
mechanism and the exact role of NADH in this process are
so far unclear.
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Here, we show that Lot6, the yeast orthologue of human
NQO1, is physically associated with the 20S proteasome. Each
proteasome barrel structure can bind to two Lot6 dimers, which
might be associated with the a-ring system. Furthermore,
recruitment of the yeast transcription factor Yap4, a member of
the yeast activator protein (Yap) family, to the quinone reductase–
20S proteasome complex is regulated by the redox state of the
flavin cofactor. Association of the transcription factor with the pre-
formed complex is shown to affect both proteasomal degradation
and localization. Hence, we conclude that Lot6 is a redox-
regulated switch that directly affects the physiological function of
the proteasome, as well as the stability and localization of yeast
transcription factor Yap4.
RESULTS AND DISCUSSION
The yeast gene lot6 (YLR011w) encodes a 21-kDa protein with a
non-covalently bound flavin mononucleotide (FMN) cofactor. The
protein adopts a flavodoxin-like fold and forms a dimer in solution
(Liger et al, 2004). We have recently shown that the protein has
quinone reductase activity that is similar to its mammalian
orthologues (Sollner et al, 2007). Although a role of the enzyme
in detoxification of quinones has been shown, the exact cellular
function of the enzyme during oxidative stress is still unclear. In an
approach to explain its cellular role, we performed pull-down
assays for the isolation of potential protein interaction partners of
Lot6. Initially, Lot6 with a carboxy-terminal hexahistidine tag was
incubated with crude extracts of wild-type yeast cells and
subsequently applied to a nickel-chelating sepharose column.
After extensive washing, the tagged protein was eluted and protein
fractions were analysed by SDS–polyacrylamide gel electrophor-
esis (SDS–PAGE). As shown in Fig 1A, additional bands (with
similar mobilities) were observed in the Lot6 fraction, which were
identified by matrix-assisted laser desorption/ionization (MALDI)
mass spectrometry and amino-terminal sequencing as several
subunits of the 20S proteasome. To confirm this finding, we
isolated the proteasome from yeast, repeated the pull-down assay
with the purified proteasome (Groll & Huber, 2005), and
subjected the pull-down fractions to Western blotting using both
Lot6 and 20S proteasome antibodies. Association of Lot6 with the
yeast 20S proteasome was clearly detected (Fig 1B). Interestingly,
Western blot analysis using Lot6 antibody showed the presence of
Lot6 traces even in the affinity-purified 20S proteasome fraction
(Fig 1B, lane 1). Furthermore, subjecting a yeast crude extract to
size-exclusion chromatography (Fig 1C) and subsequent Western
blotting showed that Lot6 coelutes with the 20S proteasome,
indicating that a stable Lot6–20S proteasome protein complex
forms in vivo.
To assess the importance of the FMN cofactor for the
interaction with the proteasome, freshly prepared apo-Lot6 was
used for the pull-down assay. The results revealed that apo-Lot6 is
unable to form a complex with the 20S proteasome, suggesting
that the flavin cofactor is required for the formation of the complex
(Fig 2, lane 5). This prompted us to take a closer look at the
potential role of the cofactor. As shown previously, Lot6 catalyses
the reduction of a series of quinones at the expense of both NADH
and NADPH (Sollner et al, 2007). Interestingly, reoxidation of
reduced Lot6 by molecular oxygen is several orders of magnitudes
slower compared with quinones (estimated kox¼ 1.1M1 s1).










































Fig 1 | Lot6 is found associated with the yeast 20S proteasome.
(A) Analysis of interaction partners of Lot6 (oxidized) by pull-down
assays using Lot6–His6 as bait. (B) Purified yeast 20S proteasome (1),
purified Lot6–His6 (2), and the first elution fraction of a pull-down assay
using Lot6 and purified yeast 20S proteasome (3) were analysed by
immunoblotting using both 20S antibody (upper panel) and Lot6
antibody (lower panel). (C) Gel filtration of crude yeast extract. Upper
panel, original trace from experiment. Fractions were precipitated
and analysed using Lot6 antibody (upper panel) and 20S antibody











































Fig 2 | Protein–protein interactions depend on the presence and redox
state of the flavin cofactor. (1) Lot6 control as used for all pull-down
experiments. (2) Oxidized (ox) Lot6 interacts with 20S proteasome from
crude yeast extract. (3, 4) Reduced (red) Lot6 binds to not only the 20S
proteasome but also Yap4. (5) Lot6 lacking the cofactor (apo-Lot6) is
unable to bind to both proteasome and Yap4. (6) When a yap4 deletion
strain is used for the interaction studies, no other interaction partner
is found. All lanes are showing 12.5% SDS–PAGE gels of pull-down
experiments. SDS–PAGE, SDS–polyacrylamide gel electrophoresis;
wt, wild type.
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reductase NQO1 (Tedeschi et al, 1995). Thus, it can be concluded
that oxygen is not a relevant oxidizing agent for reduced
Lot6 in vivo.
To probe the binding of reduced Lot6 to the proteasome, the
enzyme was reduced in two different ways: by the addition of
excess NADH or by light irradiation. By using one of these two
procedures, reduced Lot6 was again incubated with yeast crude
extract, and potential binding partners were analysed as described
above. It was found that the interaction of Lot6 with the
proteasome is independent of the redox state of the flavin (Fig 2,
lanes 2–4). However, when Lot6 is present in its reduced state
another band with a slightly lower mobility was detected (Fig 2,
lanes 3 and 4). Subjecting this band to in-gel tryptic digestion and
analysis by MALDI led to the identification of the b-Zip
transcription factor Yap4, a member of the Yap family (Nevitt
et al, 2004a, b). When the pull-down experiments were repeated
with protein extract from a yap4 knockout yeast strain, the Yap4
band was absent confirming our assignment (Fig 2, lane 6). The
occurrence of this additional binding partner is independent of the
flavin reduction method and hence does not rely on the presence
of a reduced pyrimidine nucleotide but on the redox state of the
cofactor. Conversely, Lot6 in its native dimeric state is essential for
the binding of Yap4 to the complex. Cold denaturation of Lot6
yields a stable monomer, which in its reduced form still binds to
the 20S proteasome but is no longer able to recruit Yap4 to the
complex (Fig 3A). Dissociation of Lot6 dimers into monomers
does not affect the catalytic properties of the enzyme with regard
to quinone reduction (kcat¼ 21.1±0.9 and 20.8±0.5 s1,
KM¼ 2.7±0.4 and 2.4±0.3 mM for native and monomeric Lot6,
respectively). Therefore, dimerization of Lot6 is not a prerequisite
for enzymatic activity, but is essential for formation of the
protein complex.
To determine the stoichiometry of the Lot6–20S proteasome
complex, we titrated dimeric Lot6 with 20S proteasome while
monitoring the fluorescence emission of the FMN cofactor. As
shown in Fig 3B, the titration yielded a 2:1 (Lot6:20S) stoichio-
metry, suggesting that two quinone reductases are bound per
20S proteasome. Furthermore, the titration shows that binding
of Lot6 to the proteasome is tight, as indicated by the sharp
titration end point.
We also investigated the effect of complex formation on
enzymatic activity of Lot6 and the 20S proteasome. Quinone
reductase activity was five times lower in the presence of a 10-fold
excess of 20S proteasome (data not shown). This is consistent with
the assumption that the 20S proteasome binds to or near the FMN
site of Lot6. Similarly, chymotrypsin-like activity of the protea-
some was 10 times lower in the presence of Lot6 (Fig 4A). As
substrate access is considered to be the rate-limiting step, it is
possible that Lot6 binds to the a-ring of the proteasome, thereby
hampering access to the catalytic chamber and decreasing
proteasomal activity (Groll et al, 1997).
Previous results using the human system have suggested that
association of a transcription factor with the quinone reductase–
proteasome complex prevents ubiquitin-independent proteasomal
degradation (Asher et al, 2001, 2005; Asher & Shaul, 2005; Garate
et al, 2008). For the yeast system, we also found that Yap4 is
protected from proteasomal degradation when bound to the
Lot6–20S proteasome complex (Fig 4B). However, the fact that the
localization of Yap1 is regulated by a redox-sensitive mechanism
prompted us to investigate whether the association of Yap4 with
protein interaction partners might also have implication for its
localization. Thus, we prepared homogenate, cytosol and nuclei
from stressed and non-stressed cultures. Immunoblotting revealed
the presence of Yap4 in the nucleus after induction of stress,
whereas no Yap4 was detected in the nuclei from a non-stressed
culture (Fig 4C). Hence, we propose that stress leads not only to
the dissociation of Yap4 from the Lot6–proteasome complex, but
subsequently Yap4 relocalizes to the nucleus.
Sequestration of a transcription factor by a quinone reductase–
































































Fig 3 | Stoichiometry of the 20S proteasome–Lot6–Yap4 complex.
(A) Upper panel, overlay of two gel filtrations of native dimeric (left)
and monomeric (right) Lot6. Lower panel, pull-down assays under
reduced conditions with both dimeric and monomeric Lot6. Reduced
dimeric Lot6 is able to interact with both the 20S proteasome and
Yap4, whereas reduced monomeric Lot6 can only bind to proteasome.
(B) Fluorescence determination of the stoichiometry of binding of the
20S proteasome to Lot6. Lot6 (1 mM) was titrated with 20S proteasome at
25 1C. The results of the titration are plotted as a fraction of
maximum change (DF/DFmax at 530 nm) compared with the molecular
stoichiometry of 20S proteasome–Lot6 (dimer). The insert shows titration
spectra with 20S proteasome concentrations ranging from 0 to 2.5mM.
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similar to findings in mammalian cells (Asher et al, 2001). In
humans, NQO1 interacts with the 20S proteasome and is
proposed to recruit the transcription factor p53 in an NADH-
dependent manner (Asher et al, 2001, 2005). Similarly, the
transcription factor Yap4 reported here is recruited to the
(reduced) quinone reductase–20S proteasome complex of yeast.
However, it shows only low sequence similarity to human p53
(sequence identity of 22.5%) and hence it is unclear whether Yap4
is a functional precursor of p53.
Our data indicate that the redox state of the flavin cofactor
controls the recruitment of Yap4 to the 20S proteasome in yeast
irrespective of the mode of reduction. Therefore, we propose that
the generation of the reduced state of the flavin cofactor results in
the recruitment of Yap4 to the Lot6–proteasome complex. This
would suggest that the stability and localization of the trans-
cription factor Yap4 is under direct redox control of the quinone
reductase–proteasome system. Under reducing conditions, Yap4
is bound to the Lot6–proteasome complex and thus is retained in
the cytosol (Fig 5). In the presence of quinones, Yap4 is released
from the Lot6–proteasome complex and rapidly relocalizes to the
nucleus to avoid ubiquitin-independent proteasomal degradation
(Asher et al, 2006). A similar redox controlled mechanism might
regulate the stabilization and localization of p53 and related
transcription factors in mammalian cells.
Although it seems obvious that NADPH acts as a physiological
reducing agent for the quinone reductase, the molecular nature of
the reoxidizing agent remains elusive. The biochemical data
indicate that molecular oxygen is an unlikely candidate and
suggests that this role is performed by cellular quinones. In this
context, it is important to note that quinone reductases have been
found in a wide range of eukaryotic organisms from yeast to
mammals (Deller et al, 2008), and it is therefore possible that
these enzymes have evolved as redox sensors of the proteasome,
recruiting and stabilizing transcription factors that are crucial for
the response to oxidative stress.
METHODS
Plasmids, strains and growth conditions. The S. cerevisiae yeast
strains Y00000 (BY4741 Mata his3D1 leu2D0 met15D0 ura3D0)
and Y01804 (BY4741 Mata his3D1 leu2D0 met15D0 ura3D0
yap4DHKanMX4) were obtained from the Euroscarf strain
collection. Strains were grown under aerobic conditions at 30 1C
on YPD medium.
Preparation of cell extracts. Yeast cells were collected at late
logarithmic phase and protein extracts were prepared by using
glass beads. Protein was quantified using a method described
previously (Lowry et al, 1951).
Yap4 cloning and expression. Cloning was performed using
standard techniques. The gene was integrated into pET21a
(Novagen, San Diego, CA, USA) using NdeI and XhoI restriction
sites for expression of the protein with an N-terminal hexahistidine
tag. Yap4 was coexpressed with the vector pTf16 containing the
tig chaperone (Takara Bio, Otsu, Shiga, Japan) in Escherichia coli
BL21(DE3) and purified as described for Lot6.
Pull-down assays and photoreduction. Native Lot6–His6 was
expressed and purified as described previously (Sollner et al,
2007). For interaction studies, 1.5ml of cell extract (2mg/ml

























































































Fig 4 | The physiological role of Yap4. (A) Chymotrypsin-like (CL) activity was measured in the presence of both oxidized (ox) and reduced (red) Lot6
and compared with 20S proteasome only. (B) In vitro study showing that Yap4 is protected from ubiquitin-independent proteasomal degradation
through association with reduced Lot6. Yap4 was incubated with yeast 20S proteasome, Lot6 (third and fourth panels from top) and NADH (second
and fourth panels from top). Samples were taken after 0, 30, 60 and 90min, and immunoblotted using Yap4 and Lot6 antibodies (fifth panel from
top). (C) Immunoblot of homogenate (hom), cytosol (cyt) and nucleus (nuc) preparations from non-stressed (1) and quinone-stressed (2) yeast
cultures. On treatment with naphthoquinone, Yap4 relocalizes from the cytosol to the nucleus. As a control, the distribution of Sir2 (3), a nuclear
histone deacetylase, is shown.
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5min. The protein solution was subjected to Ni-NTA resin (1ml
HiTrap Chelating HP columns; GE Healthcare, Uppsala, Sweden).
Fractions were precipitated using 15% trichloroacetic acid and
applied to SDS–PAGE. Interaction partners of reduced Lot6 were
investigated either by reduction with an excess of NADH or by
photoreduction as outlined previously (Sollner et al, 2007).
Subsequently, reduced Lot6 was transferred to a nitrogen-filled
glove bag (AtmosBag; Sigma-Aldrich, St Louis, MO, USA) and
pull-down assays were performed as described above. Fractions
were analysed by Western blotting using a primary rabbit antibody
against Lot6 (Haid & Suissa, 1983). When pull-down assays with
Lot6 and purified 20S proteasome were conducted, yeast 20S
proteasome was expressed and purified as described previously
(Groll & Huber, 2005).
Gel filtration. For the detection of the Lot6–20S proteasome
complex, 3ml of crude yeast cell extract (2mg/ml protein) was
loaded onto a HiLoadTM 16/60 SuperdexTM 200 prep grade
(Amersham Biosciences, Uppsala, Sweden) column and eluted at
a flow rate of 1ml/min. Fractions were precipitated with 15% (w/
v) ice-cold trichloroacetic acid and subjected to Western blotting
using both a primary antibody against Lot6 and a 20S proteasome
rabbit antibody (Biomol International, Exeter, UK).
Rapid reaction studies. Stopped-flow experiments were per-
formed at 4 1C using a Hi-Tech Scientific KinetAsyst SF-61 DX2
stopped-flow spectrometer. Enzyme and substrate solutions were
made anaerobic in glass tonometers by repeated cycles of
evacuation and flushing with purified argon. Oxidative half-
reactions were carried out using 20 mM Lot6 (reduced with
dithionite) in 50mM N-[tris(hydroxymethyl)methyl]-3-aminopro-
pane sulfonic acid, pH 7.4. The apparent rate constant for oxygen
was determined by mixing reduced enzyme solution with air-
saturated buffer (21% oxygen) at 25 1C.
Enzyme activity assays. Lot6 quinone reductase assays were
conducted as described previously (Sollner et al, 2007). For the
generation of monomeric Lot6, the buffer of recombinant Lot6 was
changed to 50mM phosphate, 10mM b-mercaptoethanol and
150mM NaCl, pH 7.0. The protein solution was then flash-frozen
with liquid nitrogen, slowly thawed and subjected to a HiLoad 16/
60 Superdex prep grade (Amersham Biosciences) column.
Fractions corresponding to monomeric Lot6 were concentrated
by ultracentrifugation (CentriPrep; Amicon, Millipore, Billerica,
MA, USA; 10 kDa molecular weight cut off). When Lot6 quinone
reductase assays were performed in the presence of 20S
proteasome, a 10-fold excess (50 nM) of native yeast 20S
proteasome was added.
20S proteasome activity assays were performed using native
20S proteasome (Groll & Huber, 2005). For the determination of
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Fig 5 | Proposed model for redox-dependent binding and release of Yap4 from the Lot6–20S proteasome complex. Under conditions in which the Lot6
flavin is reduced and does not get reoxidized by quinone species, Yap4 is bound to the Lot6–proteasome complex and thus is retained in the cytosol.
In the presence of quinones, Yap4 is released from the complex and relocalizes to the nucleus to induce the transcription of target genes.
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chymotrypsin-like activity against chromogenic substrate was
tested as described previously (Groll & Huber, 2005). When
reduced conditions were measured, an excess of NADH (500 mM)
was added.
Fluorescence titration. Fluorescence measurements were per-
formed with a Shimadzu RF-5301PC spectrofluorophotometer at
25 1C. Emission was recorded from 480 to 650 nm at an excitation
wavelength of 370 nm. The band width for excitation was 5 nm
and for emission it was 10 nm.
Preparation of yeast organelles. Nuclei were prepared from yeast
wild-type BY4741 cells with or without 6 h of treatment with
naphthoquinone (10 mM) in the stationary phase. Cytosol was
prepared as described previously (Zinser & Daum, 1995). Nuclei
were enriched by sucrose density gradient centrifugation (Hurt
et al, 1988; Aris & Blobel, 1991) and immunoblotted using Yap4
antibody. Sir2 was detected using a rabbit polyclonal antibody
(Santa Cruz Biotechnology, Santa Cruz, CA, USA).
MALDI–time of flight MS. We analysed MALDI–time of flight
(MALDI–TOF) with a Micro MX (Waters, Milford, MA, USA) TOF
instrument using standard procedure as in gel digestion (Shev-
chenko et al, 1996).
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